Description of an efficacious behavioral peer-driven intervention to reduce racial/ethnic disparities in AIDS clinical trials
| Autor: | Marya Gwadz, M. Riedel, A. S. Ritchie, G. Arredondo, A. Banfield, Noelle R. Leonard, Donna Mildvan, C. M. Cleland |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Male
Health Knowledge Attitudes Practice Attitude of Health Personnel media_common.quotation_subject Human immunodeficiency virus (HIV) Trust medicine.disease_cause Peer Group Education Patient Education as Topic Acquired immunodeficiency syndrome (AIDS) Intervention (counseling) medicine Humans Mass Screening Patient Navigation Selection Bias Mass screening media_common Selection bias Acquired Immunodeficiency Syndrome Clinical Trials as Topic business.industry Patient Selection Public Health Environmental and Occupational Health Peer group Original Articles Fear Hispanic or Latino medicine.disease Racial ethnic Black or African American Clinical trial Female business Clinical psychology |
| Zdroj: | Health Education Research. 28:574-590 |
| ISSN: | 1465-3648 0268-1153 |
| DOI: | 10.1093/her/cyt052 |
| Popis: | AIDS clinical trials (ACTs) are critical to the development of new treatments for HIV infection. However, people of color living with HIV/AIDS are involved in ACTs at disproportionally low rates, with African-Americans experiencing the greatest under-representation. In this article, we describe the core elements and key characteristics of a highly efficacious multi-component peer-driven intervention (PDI) designed to increase rates of screening for and enrollment into ACTs among African-American and Latino/Hispanic individuals, by addressing the main complex, multi-level barriers they experience to ACTs. We discuss the process of developing the intervention, the theoretical models guiding its delivery format and content, and provide an overview of the intervention's components. We then use brief case studies to illustrate a number of key issues that may arise during intervention implementation. Finally, we describe lessons learned and provide recommendations for the PDI's uptake in clinical and clinical trials settings. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|